Cargando…

P342: RAS PATHWAY ACTIVATION REMODELS THE BONE MARROW MICROENVIRONMENT IN ACUTE LYMPHOBLASTIC LEUKAEMIA

Detalles Bibliográficos
Autores principales:	Ferrao Blanco, Mauricio, Kester, Lennart, Hehir-Kwa, Jayne, den Boer, Monique, Heidenreich, Olaf, Vormoor, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428435/ http://dx.doi.org/10.1097/01.HS9.0000968280.58510.82

Ejemplares similares

Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations
por: Rehe, Klaus, et al.
Publicado: (2013)

Leukemia suppressing normal bone marrow: how long does it last?
por: Blanco, Mauricio Nicolas Ferrao, et al.
Publicado: (2023)

Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia
por: Elder, A, et al.
Publicado: (2017)

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia
por: Pal, D, et al.
Publicado: (2016)

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial
por: Menne, Tobias, et al.
Publicado: (2022)

Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia.
por: Kearney, P. J., et al.
Publicado: (1979)

Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia
por: Shi, Yuzhe, et al.
Publicado: (2020)

Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM
por: Matheson, Elizabeth C., et al.
Publicado: (2019)

Extensive Bone Marrow Necrosis: A Rare Presentation of Acute Lymphoblastic Leukaemia
por: Ranathunga, I., et al.
Publicado: (2020)

Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia.
por: Trerè, D., et al.
Publicado: (1994)

Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia
por: Basnett, Jordan, et al.
Publicado: (2017)

Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
por: Sinclair, Paul B., et al.
Publicado: (2023)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood
por: Scarffe, J. H., et al.
Publicado: (1980)

Non‐tumour bone marrow lymphocytes correlate with improved overall survival in childhood acute lymphoblastic leukaemia
por: Edwin, Claire, et al.
Publicado: (2016)

Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia
por: Alruwetei, Abdulmohsen M., et al.
Publicado: (2020)

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.
por: Klumper, E., et al.
Publicado: (1995)

Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003)

Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.
por: Blatt, J., et al.
Publicado: (1984)

Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia.
por: Thorne, R., et al.
Publicado: (1998)

Computer-Aided Diagnosis of Acute Lymphoblastic Leukaemia
por: Shafique, Sarmad, et al.
Publicado: (2018)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
por: Vanheule, Eva, et al.
Publicado: (2020)

Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
por: Kook, Hye Won, et al.
Publicado: (2022)

Editorial: Long-read sequencing—Pitfalls, benefits and success stories
por: Wohlers, Inken, et al.
Publicado: (2023)

Health Tract No. 342: Lunacy
Publicado: (1868)

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all
por: Kuiper, Roland P., et al.
Publicado: (2021)

Response and Resistance to MEK Inhibition in Leukaemias Initiated by Hyperactive Ras
por: Lauchle, Jennifer O., et al.
Publicado: (2009)

Daycare attendance and risk of childhood acute lymphoblastic leukaemia
por: Ma, X, et al.
Publicado: (2002)

Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia
por: Kwan, M L, et al.
Publicado: (2005)

The relationship of incidence of childhood lymphoblastic leukaemia to social class.
por: McWhirter, W. R.
Publicado: (1982)

What Role for Angiogenesis in Childhood Acute Lymphoblastic Leukaemia?
por: Schneider, P., et al.
Publicado: (2011)

Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia
por: Mansur, Marcela B., et al.
Publicado: (2015)

Hypereosinophilia: A rare presentation of acute lymphoblastic leukaemia
por: Narayanan, G, et al.
Publicado: (2018)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia
por: Collord, Grace, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_517h5j2387r35c461b6pqb6g11